Medical Journals

Level of Expression of Il-13r Alpha 2 Impacts Receptor Distribution and Il-13 Signaling.

Authors:
  • Daines Michael O
  • Tabata Yasuhiro
  • Walker Bradley A
  • Chen Weiguo
  • Warrier Manoj R
  • Basu Saswata
  • Hershey Gurjit K Khurana

From: Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children’ Hospital Medical Center, OH 45229, USA

Journal of immunology (Baltimore, Md. : 1950)

  • Publish Date: Jun 2006
  • ISSN: 0022-1767
  • Volume: 176
  • Issue: 12
  • Pages: 7495-501
  • Medium: Print
  • Language: English
  • Citation (JAMA): Daines Michael O, Tabata Yasuhiro, Walker Bradley A, et al. Level of Expression of Il-13r Alpha 2 Impacts Receptor Distribution and Il-13 Signaling.. J. Immunol. Jun 2006;176:7495-501

Abstract

IL-13, a critical cytokine for allergic inflammation, exerts its effects through a complex receptor system including IL-4Ralpha, IL-13Ralpha1, and IL-13Ralpha2. IL-4Ralpha and IL-13Ralpha1 form a heterodimeric signaling receptor for IL-13. In contrast, IL-13Ralpha2 binds IL-13 with high affinity but does not signal. IL-13Ralpha2 exists on the cell surface, intracellularly, and in soluble form, but no information is available regarding the relative distributions of IL-13Ralpha2 among these compartments, whether the compartments communicate, and how the relative expression levels impact IL-13 responses. Herein, we investigated the distribution of IL-13Ralpha2 in transfected and primary cells, and we evaluated how the total level of IL-13Ralpha2 expression impacted its distribution. Our results demonstrate that the distribution of IL-13Ralpha2 is independent of the overall level of expression. The majority of the IL-13Ralpha2 protein existed in intracellular pools. Surface IL-13Ralpha2 was continually released into the medium in a soluble form, yet surface expression remained constant supporting receptor trafficking to the cell surface. IL-13Ralpha2 inhibited IL-13 signaling proportionally to its level of expression, and this inhibition could be overcome with high concentrations of IL-13.

Mesh Headings (Keywords): Animals, Cell Membrane, Clone Cells, Dose-Response Relationship, Immunologic, Humans, Interleukin-13, Interleukin-13 Receptor alpha1 Subunit, Interleukin-4, Intracellular Fluid, Ligands, Mice, Mice, Inbred C3H, Protein Binding, Receptors, IgE, Receptors, Interleukin, Receptors, Interleukin-13, Signal Transduction, Solubility, Spleen, Transfection, U937 Cells


Check for Full Text / PubMed Unique Identifier (PMID): 16751396


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.